Hepatitis B virus: molecular characteristics and subtypes

1993 ◽  
pp. 61-68
Author(s):  
Edouard Kurstak
2001 ◽  
Vol 34 ◽  
pp. 15-16 ◽  
Author(s):  
J. Hou ◽  
R. Schilling ◽  
H.L.A. Janssen ◽  
R.A. Heijtink ◽  
R. Williams ◽  
...  

2010 ◽  
Vol 83 (1) ◽  
pp. 189-193 ◽  
Author(s):  
Takako Utsumi ◽  
Hak Hotta ◽  
Maria Inge Lusida ◽  
Yoshitake Hayashi ◽  
Soetjipto ◽  
...  

2009 ◽  
Vol 48 (2) ◽  
pp. 357-362 ◽  
Author(s):  
Q. Yuan ◽  
S.-H. Ou ◽  
C.-R. Chen ◽  
S.-X. Ge ◽  
B. Pei ◽  
...  

2004 ◽  
Vol 40 ◽  
pp. 129
Author(s):  
S. Le ◽  
T. Nguyen ◽  
D. Dinh ◽  
B. Vu ◽  
P. Kremsner ◽  
...  

2017 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Nguyen Hoa Trang ◽  
Bui Thi Ton That ◽  
Tran Thi Thanh Thanh ◽  
Le Ngoc Chau ◽  
Tran Tan Thanh ◽  
...  

2016 ◽  
Vol 10 (04) ◽  
pp. 427-431 ◽  
Author(s):  
Yiying Wang ◽  
Lugang Yu ◽  
Hui Zhou ◽  
Zhiwei Zhou ◽  
Huijuan Zhu ◽  
...  

Introduction: Previous studies have indicated that the patients with psychiatric illness were at higher risk of hepatitis B virus (HBV) infection. However, the efficacy of hepatitis B vaccine in schizophrenia patients remains unclear. Methodology: Between June 2014 and January 2015, 415 schizophrenia patients and 3,038 controls who had been routinely immunized as infants were recruited in the present study. Hepatitis B surface antigen (HBsAg), HBsAb, and HBV DNA were detected with commercial methods according to the manufacturer’s protocol. A 600-bp region of the S gene (region nt236–nt835) was amplified by nested polymerase chain reaction (PCR). The genotypes of isolated HBV were identified using phylogenetic analysis by the neighbor-joining algorithm in the software MEGA version 4.1. Results: The seroprevalence of HBsAg in schizophrenia patients was 6.75%, which was significantly higher than 3.32% measured in controls. HBsAg prevalence was 7.94% in male schizophrenia patients and 5.47% in female schizophrenia patients, while it was only 4.04% in males and 2.08% in females in the control group. The HBsAb seroprevalence rate was 58.31% in schizophrenia patients and 59.94% in non-schizophrenia controls. Moreover, one HBV strain in the schizophrenia group presented I126S vaccine escape mutation (5.88%), while three HBV isolates showed Q129H, M133L, and G145R vaccine escape mutations in the control group (6.81%). Conclusions: Schizophrenia patients are at higher risk for HBV infection, even those who had received routine immunization. Therefore, a booster HB vaccination targeted at schizophrenia patients should be considered in the future.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Aurélie Deroubaix ◽  
Anna Kramvis

AbstractHBeAg, a non-particulate protein of hepatitis B virus (HBV), is translated from the precore/core region as a precursor, which is post-translationally modified. Subgenotype A1 of HBV, which is a risk factor for hepatocellular carcinoma (HCC), has unique molecular characteristics in the basic core promoter/precore regions. Carriers of A1 exhibit early HBeAg loss. We sought to further characterize the precore proteins of A1 in vitro. HuH-7 cells were transfected with subgenomic constructs expressing individual precore proteins. Western blot analysis using DAKO anti-core antibody showed the expected sizes and a 1 kDa larger band for P22, P20 and P17. Using confocal microscopy, a cytoplasmic accumulation of HBeAg and precursors was observed with P25-expressing plasmid, whereas P22 localized both in the cytoplasm and nucleus. P20 and P17, which lack the carboxy end of P22 showed strong nuclear accumulation, implicating a nuclear localization signal in the N-terminal 10 amino acids. G1862T, unique to subgenotype A1, is frequently found in HBV from HCC patients. P25 with G1862T showed delayed and reduced HBeAg expression/secretion. Knock-out of core in the replication competent clones led to precore protein accumulation in the cytoplasm/perinuclear region, and decreased HBeAg secretion. Knock-out of precore proteins increased HBsAg secretion but intracellular HBsAg expression was unaffected. Over-expression of precore proteins in trans led to decreased HBsAg expression and secretion. Intracellular trafficking of HBV A1 precore proteins was followed. This was unaffected by the CMV promoter and different cell types. In the viral context, precore protein expression was affected by absence of core, and affected HBsAg expression, suggesting an interrelationship between precore proteins, HBcAg and HBsAg. This modulatory role of HBeAg and its precursors may be important in viral persistence and ultimate development of HCC.


Sign in / Sign up

Export Citation Format

Share Document